SCHEMBL23355335

SCHEMBL23355335

CC(C)(C)NC(=O)c1csc(Oc2ccc(NC(=O)O)c(F)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
ABL1 P00519 3/20 0.41
MAPK14 Q16539 8/20 0.40
KDR P35968 3/20 0.40
RAF1 P04049 2/20 0.40
RET P07949 2/20 0.40
KIT P10721 2/20 0.40
BCR P11274 2/20 0.40
FGFR1 P11362 2/20 0.40
BRAF P15056 2/20 0.40
PDGFRA P16234 2/20 0.40
FLT1 P17948 2/20 0.40
EPHA1 P21709 2/20 0.40
TTK P33981 2/20 0.40
FLT4 P35916 2/20 0.40
FLT3 P36888 2/20 0.40
MAPKAPK2 P49137 2/20 0.40
CLK1 P49759 2/20 0.40
LIMK1 P53667 2/20 0.40
CDK17 Q00537 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23368031 0.89 CYP17A1 (0.41) LMNAABL1MAPK14KDRRAF1
SCHEMBL21612809 0.79 CYP17A1 (0.42) LMNAABL1MAPK14KDRRAF1
SCHEMBL23355378 0.79 LMNA (0.37) LMNAABL1KDRKITPDGFRA
SCHEMBL29834712 0.79 KDR (0.41) LMNAABL1MAPK14KDRRAF1
SCHEMBL29834629 0.76 CYP17A1 (0.42) LMNAABL1MAPK14KDRRAF1
SCHEMBL23355406 0.76 SCN9A (0.36) LMNAABL1MAPK14KDRBRAF
SCHEMBL21612852 0.75 ABCB1 (0.44) LMNAKDRBRAFFLT1SMN1; SMN2
SCHEMBL29834721 0.75 ABCB1 (0.43) LMNAABL1MAPK14KDRRAF1
SCHEMBL23355472 0.75 CA1 (0.35) LMNAABL1MAPK14KDRKIT
SCHEMBL23355431 0.75 RAB9A (0.51) LMNASMN1; SMN2RAB9AANO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822263-A1 BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2021-05-19 EP disclosed